lomustine and dacarbazine

lomustine has been researched along with dacarbazine in 199 studies

Research

Studies (199)

TimeframeStudies, this research(%)All Research%
pre-199068 (34.17)18.7374
1990's38 (19.10)18.2507
2000's48 (24.12)29.6817
2010's42 (21.11)24.3611
2020's3 (1.51)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Gaeta, JF; Mirand, EA; Murphy, GP; Varkarakis, MJ1
Salem, PA1
Bruntsch, U; Gallmeier, WM; Osieka, R; Schmidt, CG; Seeber, S1
Dold, U1
Barrett, A; Bradbeer, JW; Gazet, JC; Peckham, MJ1
Dowd, PM; Everall, JD1
Chan, EY; Cohen, RJ1
Baxter, D; Cunningham, TJ; Horton, J; Nelson, L; Olson, KB; Rosenbaum, C; Sponzo, RW; Taylor, SG1
Ahmann, DL; Bisel, HF; Creagan, ET; Eagan, RT; Edmonson, JH; Hahn, RG1
Benjamin, RS1
Domas, J; Gauci, L; Pujol, H; Serrou, B1
Comis, RL1
Burgess, MA; Gottlieb, J; Gutterman, JU; Hersh, EM; Mavligit, GM; Reed, R1
Hill, G; Johnson, RO; Krementz, E; Metter, G; Wilson, W1
Carbone, PP; Costello, W1
Levin, VA; Wilson, CB1
Cruz, AB; Davis, HL; Fletcher, WS; Golomb, FM; Grage, T; Hill, GJ; Johnson, RO; Metter, G; Wilson, WL1
Aranha, GV; Grage, TB1
Carter, RD; Fletcher, WS; Golomb, FM; Grage, TB; Hill, GJ; Krementz, ET; Metter, GE; Minton, JP; Sparks, FC1
Dickey, C; Gerner, RE; Moore, GE1
Jacobsen, GK; Povlsen, CO1
Hahka-Kemppinen, M; Muhonen, T; Pyrhönen, S1
Doherty, VR; MacKie, RM; Stables, GI1
Dölken, G; Fuchs, R; Gerhartz, H; Hagen-Aukamp, U; Hiller, E; Löffler, M; Petsch, S; Pflüger, KH; Pfreundschuh, M; Rühl, U2
Bailey, NM; Hagemeister, FB; Liang, JC; Sen, P1
Bliss, JM; Gore, ME; Lakhani, S; McElwain, TJ; Perren, TJ; Selby, P1
Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, JJ; Merke, DP; Myers, J; Straus, DJ; Yahalom, J1
Aeppli, D; Day, DL; Heise, R; Lee, CK; McClain, KL; Woods, WG1
Fiedler, H; Hetschko, I; Lübbe, D; Taube, KM; Wohlrab, W; Wozniak, KD1
Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S1
al-Idrissi, HY; Ibrahim, EM1
Glover, DJ1
Baker, AR; Barth, RJ; Venzon, DJ1
Joensuu, H1
Bizzari, JP; Deloffre, P; Etienne, MC; Fischel, JL; Formento, P; Frenay, M; Gioanni, J; Milano, G1
Bonadonna, G; Bonfante, V; Santoro, A; Valagussa, P; Viviani, S2
Kholin, AV1
Bonadonna, G; Santoro, A; Valagussa, P1
Gabryś, K; Kotlarek-Haus, S; Sciborski, R2
Diehl, V; Georgii, A; Gerhartz, H; Hiller, E; Löffler, M; Pfreundschuh, M; Rühl, U; Smith, K1
Koziner, B; Zori Comba, A1
Diehl, V; Fuchs, R; Loeffler, M; Pflüger, KH; Pfreundschuh, MG; Schoppe, WD1
Foltz, AT; York, RM1
Carella, AM; Cimino, G; Congiu, AM; Coser, P; Gaozza, E; Mangoni, L; Mazza, P; Meloni, G; Ricci, P; Visani, G1
Bladé, J; Cervantes, F; Montserrat, E; Reverter, JC; Rozman, C1
Avril, MF1
Straus, DJ1
Cartei, G; Ceschia, T; Clocchiatti, L; Fasola, G; Galletti, D; Marsilio, P; Morandini, G; Sibau, A1
Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, J; Lee, BJ; Merke, D; Myers, J; Nisce, LZ; Straus, DJ1
English, JS; Lever, RS; MacKie, RM; Young, DW1
Bychkov, MB1
Bleyer, WA; Geyer, JR; Heideman, RL; Kosnik, EJ; Milstein, JM; Morris, JD; Mulne, AF; Pendergrass, TW; Ruymann, FB; Stuntz, JT1
Gundersen, S; Høie, J; Pihl, A; Tveit, KM1
Martz, G; Stahel, RA1
Brunat-Mentigny, M; Chastagner, P; Czorny, A; Lapras, C; Olive, D; Philip, T; Zucker, JM1
Brennan, MF; DeCosse, JJ; Greenall, MJ; Magill, GB1
Kogonia, LM; Moros, LW; Perevodchikova, NJ1
Carmo-Pereira, J; Costa, FO; Henriques, E1
Chessa, A; Desogus, A; Floris, C; Muggiano, A; Sulis, E; Tedde, A; Turno, R1
Hansson, J; Lagerlöf, B; Ringborg, U; Strander, H1
Hagen, S; Klepp, O; Stridsklev, IC1
Gamble, JF; Loh, KK; Rodgers, RW; Shullenberger, CC1
Bonadonna, G1
Bond, WH; Chenoweth, L; Einhorn, LH; Stevens, EE; Williams, SD1
Diehl, V; Peters, HD; Schmoll, HJ; von Roemeling, R; Weiss, J1
Arlin, Z; Gee, T; Kempin, S; Koziner, B; Lee, BJ; McCormick, B; Mertelsmann, R; Myers, J; Nisce, LZ; Straus, DJ1
Khan, MS; Ross, WM1
Cabanillas, F; Hagemeister, F; Tannir, N; Velasquez, W1
Harker, WG; Kushlan, P; Rosenberg, SA1
Bychkov, MB; Perevodchikova, NI1
Bernengo, MG; Doveil, GC; Lisa, F; Meregalli, M1
Hill, GJ; Hill, HZ; Krementz, ET1
Fodstad, O; Olsnes, S; Pihl, A; Tveit, KM1
Endresen, L; Fodstad, O; Pihl, A; Rugstad, HE; Tveit, KM1
Fodstad, O; Pihl, A; Tveit, KM1
Gordy, DD; Murray, JL; Robertson, DM; Wilkinson, CP1
Aass, N; Fodstad, O; Pihl, A2
al-Katib, A; Andersen, J; Bishop, CR; Hussein, ME; Karanes, C; Khanuja, PS; Smith, MR1
Hahka-Kemppinen, M; Muhonen, T; Pakkala, S; Pyrhönen, S1
Gröhn, P; Korpela, M; Kumpulainen, E; Vuoristo, M1
Allen, PK; Besa, P; Cabanillas, F; Cox, JD; Hagemeister, FB; McLaughlin, P; Preti, A; Rodriguez, A; Swan, F1
Alessandrino, EP; Astori, C; Bernasconi, P; Brusamolino, E; Canevari, A; Castelli, G; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G1
Gröhn, P; Joensuu, H; Kellokumpu-Lehtinen, P; Korpela, M; Kumpulainen, E; Nevantaus, A; Tiusanen, K; Turunen, M; Vuoristo, MS1
Asko-Seljavaara, S; Hahka-Kemppinen, M; Jekunen, A; Muhonen, T; Pyrhönen, S; Virolainen, M1
Coates, AS; Segelov, E1
Baer, JC; Freeman, AA; Margison, GP; Newlands, ES; Rafferty, JA; Watson, AJ1
Ilveskoski, I; Lanning, M; Mäkipernaa, A; Perkkiö, M; Pihko, H; Saarinen, UM; Salmi, TT; Wiklund, T1
Hahka-Kemppinen, M; Hernberg, M; Muhonen, T; Pyrhönen, S; Turunen, JP1
Diehl, V; Geilen, W; Hasenclever, D; Loeffler, M; Nisters-Backes, H; Pfreundschuh, M; Ruehl, U; Sieber, M; Smith, K; Tesch, H1
Bruske, T; Kreysel, HW; Reinhold, U1
Hahka-Kemppinen, M; Kangas, L; Muhonen, T; Pyrhönen, S1
Vuoristo, MS1
Andrieu, JM; Briere, J; Casassus, P; Desablens, B; Hunault, M; Ifrah, N; Jais, JP; Le Maignan, C; Moreau, P1
de Mulder, PH; Jansen, RL; Muller, EW; Punt, CJ; van Herpen, CM; Vreugdenhil, G1
Berd, D; De Potter, P; Mastrangelo, MJ; Nathan, FE; Sato, T; Shield, JA; Shields, CL1
Hahka-Kemppinen, M; Muhonen, T; Nordling, S; Pyrhönen, S1
Shimoyama, M; Tsushita, K; Utsumi, M1
Darling, JL; Sankar, A; Thomas, DG1
Jedrzejczak, WW1
Gadjeva, V; Raikova, E; Zheleva, A1
Hahka-Kemppinen, M; Hemminki, K; Jansèn, CT; Kumar, R; Punnonen, K; Pyrhönen, S; Sauroja, I; Smeds, J; Talve, L; Vlaykova, T1
Eich, HT; Eich, PD; Micke, O; Müller, R; Staar, S; Stützer, H1
Giraldi, T; Perissin, L; Rapozzi, V; Zorzet, S1
Chan, C; O'Day, J1
Chinot, O1
Bardenheuer, W; Flasshove, M; Jansen, M; Moritz, T; Seeber, S; Sorg, UR1
Hahka-Kemppinen, M; Kähäri, VM; Nikkola, J; Pyrhönen, S; Vihinen, P; Vlaykova, T1
Croteau, D; Mikkelsen, T1
Eskelin, S; Hahka-Kemppinen, M; Kivelä, T; Muhonen, T; Nikkanen, V; Pyrhönen, S; Summanen, P; Tarkkanen, A1
Barista, I; Cabanillas, F; Chronowski, GM; Cox, JD; Ha, CS; Hagemeister, FB; Hess, MA; Sarris, AH; Tucker, SL; Wilder, RB1
Basso, U; Berti, F; Brandes, AA; Ermani, M; Gardiman, M; Monfardini, S; Pinna, G; Rotilio, A; Scienza, R; Vastola, F1
Baayen, HC; Barkhof, F; Boogerd, W; Castelijns, JA; Elkhuizen, PH; Heimans, JJ; Postma, TJ; Uitdehaag, BM; Vos, MJ1
Baron, B; Boogerd, W; Bravo Marques, J; Chinot, O; De Beule, N; Kros, JM; Taphoorn, MJ; van den Bent, MJ; van der Rijt, CC; Vecht, CJ1
Neville, F; Nystrom, ML; Oliver, RT; Shamash, J; Steele, JP1
Gore, M; Hahka-Kemppinen, M; Hansson, J; Humblet, Y; Kivelä, T; Kloke, O; Kruit, WH; Kumpulainen, E; Parvinen, LM; Pyrhönen, S; Suciu, S; Vuoristo, MS1
Bellei, M; Brice, P; Brugiatelli, M; Carella, AM; Colombat, P; Di Renzo, N; Fabbiano, F; Federico, M; Gisselbrecht, C; Goldstone, A; Luminari, S; Moretti, L; Nagler, A1
Baumgartner, G; Budinsky, A; Czech, T; Dieckmann, K; Fazeny-Dörner, B; Gyries, A; Killer, M; Marosi, C; Muhm, M; Piribauer, M; Prayer, D; Rössler, K; Ungersböck, K; Veitl, M1
Gadjeva, V; Lazarova, G; Zheleva, A1
Engelhard, HH; Mundt, A; Stelea, A1
Eisen, TG; Lens, MB1
Bourg, V; Chanalet, S; Chatel, M; Fontaine, D; Frenay, M; Lebrun, C; Lonjon, M; Michiels, JF; Paquis, P; Ramaioli, A; Vandenbos, F1
Chamberlain, MC2
Carpentier, A; Cartalat-Carel, S; Chinot, O; Cougnard, J; Delattre, JY; Djafari, L; Duffau, H; Gervais, H; Hoang-Xuan, K; Honnorat, J; Laigle, F; Mokhtari, K; Napolitano, M; Sanson, M; Taillandier, L; Taillibert, S1
de Bruin, HG; de Wit, MC; Eijkenboom, W; Sillevis Smitt, PA; van den Bent, MJ1
Allgeier, A; Brandes, AA; Enting, RH; Frenay, M; Kros, JM; Menten, J; Stege, EB; Taphoorn, MJ; Tosoni, A; Triebels, VH; van den Bent, MJ; van Heuvel, I1
Hahka-Kemppinen, MH; Hernberg, MM; Pyrhönen, SO1
Hahka-Kemppinen, M; Kellokumpu-Lehtinen, P; Korpela, M; Parvinen, LM; Pyrhönen, S; Seppä, H; Vuoristo, MS1
Bonaccorsi, P; Borroni, RG; Bottoni, U; Calvieri, S; Clerico, R; Devirgiliis, V; Panasiti, V; Trasimeni, G1
Comella, P; Formato, R; Iaffaioli, RV; Muto, P; Pisano, A; Quattrin, S; Tafuto, S; Tortoriello, A1
Angelucci, E; Baldini, L; Bordonaro, R; Broglia, C; Cavanna, L; Chisesi, T; Deliliers, GL; Federico, M; Gobbi, PG; Levis, A; Liberati, M; Merli, F; Pavone, V; Santini, G; Stelitano, C; Vitolo, U1
Brandes, AA; Ermani, M; Gardiman, M; Ghimenton, C; Iuzzolino, P; Nicolardi, L; Reni, M; Rotilio, A; Sotti, G; Tosoni, A1
Landi, A; Piccirilli, M; Salvati, M1
Bamberg, M; Blaschke, B; Herrlinger, U; Hundsberger, T; Koch, D; Kortmann, RD; Loeser, S; Meyermann, R; Reifenberger, G; Rieger, J; Sommer, C; Steinbach, JP; Tan, TC; Weller, M; Wick, W1
Mabasa, VH; Taylor, SC1
Bate, SC; Beirne, DA; Eisen, TG; Gibbens, IM; Gore, ME; Hughes, SA; Larkin, JM; Patel, PM; Thomas, K1
Dimov, A; Gadjeva, V; Georgieva, N1
Choi, JD; Friedman, AH; Powers, CJ; Sampson, JH; Vredenburgh, JJ1
Adamson, PC; Blaney, SM; Flom, L; Ingle, AM; Jakacki, RI; Pollack, IF; Prados, MD; Timmerman, R; Yates, A; Zhou, T1
Ashley, DM; Dobrovic, A; Drummond, KJ; Friedman, HS; Gan, HK; Hawkins, CJ; Johns, TG; Kaye, AH; Lovric, MM; Maxwell, JA; Mikeska, T; Riffkin, CD1
Diehl, V; Evens, AM; Hutchings, M1
Baumert, BG; Stupp, R1
Al-Jamal, RT; Eskelin, S; Kivelä, T; Pyrhönen, S1
Bähr, O; Glas, M; Happold, C; Herrlinger, U; Kortmann, RD; Reifenberger, G; Rieger, J; Steinbach, JP; Weller, M; Wick, W; Wiewrodt, D1
Konishi, N; Nakamura, M; Nakase, H; Shimada, K1
Nishikawa, R1
DeAngelis, LM1
Bamberg, M; Engel, C; Ernemann, U; Felsberg, J; Hartmann, C; Ketter, R; Koeppen, S; Kortmann, RD; Meisner, C; Meyermann, R; Pietsch, T; Rapp, M; Reifenberger, G; Sabel, MC; Stockhammer, F; Stoffels, M; von Deimling, A; Weller, M; Wick, W; Wiestler, OD1
Delashaw, JB; Doolittle, ND; Gahramanov, S; Guillaume, DJ; Hedrick, NA; Neuwelt, EA1
Agha, CA; Elias, DA; Fathallah-Shaykh, HM; Hassan, A; Ibrahim, S1
Bekele, BN; Bobustuc, GC; Colman, H; Conrad, CA; Gilbert, MR; Groves, MD; Hsu, SH; Levin, VA; Puduvalli, VK; Qiao, W; Walbert, T; Yung, WK1
Kim, JH; Kim, ST; Kim, WS; Kong, DS; Kwon, KH; Lee, JI; Lim, DH; Nam, DH; Park, K; Suh, YL1
Arnold, L; Faoro, D; Gerber, NU; Grotzer, MA; Haybaeck, J; Hegi, M; Hürlimann, ML; Mittelbronn, M; Rutkowski, S; Sciuscio, D; Shalaby, T; von Bueren, AO1
Beall, S; Brada, M; Collins, VP; Erridge, S; Gabe, R; Gattamaneni, R; Hopkins, K; Lee, SM; Levy, D; Rampling, R; Saran, F; Stenning, S; Thompson, LC1
Abramov, ME; Artamonov, DN; Gorbacheva, LB; Tronov, VA1
Abrey, LE; Aldape, KD; Ashby, LS; Cairncross, JG; Chamberlain, MC; Cloughesy, TF; DeAngelis, LM; Eichler, AF; Fisher, BJ; Green, RM; Iwamoto, FM; Jhanwar, SC; Kamar, FG; Lassman, AB; Ligon, KL; Louis, DN; Mason, WP; Paleologos, NA; Panageas, KS; Rivera, AL; Robins, HI; Rocque, BG; Roldán, GB; Rosenblum, MK; Schiff, D; Weaver, SA; Wen, PY1
Abramov, ME; Artamonov, DN; Gorbacheva, LB; Lichinitser, MR; Tronov, VA1
Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT1
Baldini, L; Bellei, M; Bordonaro, R; Chisesi, T; Federico, M; Gobbi, P; Levis, A; Liberati, M; Luminari, S; Marcheselli, L; Merli, F; Montanini, A; Pavone, V; Pesce, EA; Stelitano, C; Vitolo, U1
Ivanov, VG; Korytova, LI; Masliukova, EA; Meshechkin, AV; Zhabuna, RM1
Audrain, O; Carsin, B; Gedouin, D; Hamlat, A; Lecouillard, I; Lesimple, T; Louvel, G; Mesbah, H; Quillien, V; Riffaud, L; Vauleon, E1
Filss, C; Glas, M; Hadizadeh, DR; Herrlinger, U; Kuchelmeister, K; Langen, KJ; Mack, F; Pietsch, T; Schäfer, N; Schüller, H; Scorzin, J; Simon, M; Stuplich, M; Urbach, H1
Ducray, F; Lekoubou, A; Viaccoz, A1
Brada, M; Chan, R; Collins, VP; Di, Y; Gabe, R; Ichimura, K; Pearson, D; Stenning, SP; Thompson, LC1
Chapet, S; Lévy, S; Mazeron, JJ1
Ameratunga, MS; Grant, R; Khasraw, M; Pavlakis, N; Wheeler, H1
Lok, E; Swanson, KD; Wong, ET1
Schiff, D1
Levin, VA1
Rinne, ML; Wen, PY1
Du Four, S; Duerinck, J; Everaert, H; Hau, P; Michotte, A; Neyns, B; Sander, W; Van Binst, AM1
Lassman, AB1
Akalan, N; Akyuz, C; Cengiz, M; Eren, G; Gurkaynak, M; Ozyigit, G; Varan, A; Yazici, G; Yüce, D; Zorlu, F1
Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C1
Abuali, I; Grossman, SA; Lu, Y; Strowd, RE; Ye, X1
Bíró, T; Buzás, K; Endrész, V; Gyukity-Sebestyén, E; Harmati, M; Katona, RL; Kemény, L; Marton, A; Nagy, K; Németh, IB; Oláh, J; Tubak, V; Vígh, L; Vizler, C; Zvara, Á1
Bartolotti, M; Brandes, AA; Franceschi, E; Tosoni, A1
Brat, DJ; Burger, PC; Buxton, A; Cohen, KJ; Eckel, SP; Hamilton, RL; Jakacki, RI; Krailo, MD; Lavey, RS; Pollack, IF; Rosenblum, MK; Zhou, T1
Felsberg, J; Gramatzki, D; Hentschel, B; Hofer, S; Krex, D; Reifenberger, G; Roth, P; Rushing, EJ; Schnell, O; Simon, M; Weller, M; Westphal, M; Wick, W1
Guo, J; Parasramka, S; Rosenfeld, M; Talari, G; Villano, JL1
Buslei, R; Distel, L; Fietkau, R; Putz, F; Stritzelberger, J1
Koskivuo, I; Lahtela, V; Mattila, K; Pyrhönen, S; Raanta, P; Vihinen, P1
Ameratunga, M; Grant, R; Khasraw, M; Pavlakis, N; Simes, J; Wheeler, H1
Kortmann, RD; Seidel, C1
Brehmer, S; Bullinger, L; Giordano, FA; Glas, M; Goldbrunner, R; Grauer, O; Hau, P; Herrlinger, U; Kowalski, T; Krex, D; Potthoff, AL; Ringel, F; Sabel, M; Schäfer, N; Schaub, C; Schmidt-Graf, F; Schneider, M; Schnell, O; Seidel, C; Steinbach, JP; Tabatabai, G; Tonn, JC; Tzaridis, T; Vajkoczy, P; Vatter, H; Weller, J; Zeiner, PS; Zeyen, T1
Fuchs, D; Morandi, L; Nytko, KJ; Rohrer Bley, C; Tonon, C; Weyland, MS1
Duffy, C; Galldiks, N; Glas, M; Goldbrunner, R; Grauer, O; Hattingen, E; Hau, P; Herrlinger, U; Krex, D; Nitsch, L; Paech, D; Potthoff, AL; Radbruch, A; Schäfer, N; Schaub, C; Schlegel, U; Schneider, M; Seidel, C; Steinbach, JP; Stummer, W; Tabatabai, G; Tzaridis, T; Weller, J; Zeiner, PS; Zeyen, T1

Reviews

30 review(s) available for lomustine and dacarbazine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Advances in cancer chemotherapy.
    Le Journal medical libanais. The Lebanese medical journal, 1975, Volume: 28, Issue:1

    Topics: Bleomycin; Burkitt Lymphoma; Carcinoma, Basal Cell; Choriocarcinoma; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Female; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitosis; Neoplasms; Pregnancy; Skin Neoplasms; Vincristine

1975
Chemotherapy of malignant melanoma.
    World journal of surgery, 1979, Jul-30, Volume: 3, Issue:3

    Topics: Antineoplastic Agents; BCG Vaccine; Dacarbazine; Drug Therapy, Combination; Humans; Lomustine; Melanoma; Nitrosourea Compounds; Skin Neoplasms

1979
DTIC (NSC-45388) in malignant melanoma: a perspective.
    Cancer treatment reports, 1976, Volume: 60, Issue:2

    Topics: Animals; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Humans; Lomustine; Melanoma; Mice; Neoplasm Metastasis; Nitrosourea Compounds; Remission, Spontaneous; Triazenes

1976
Chemotherapy: the agents in current use.
    Seminars in oncology, 1975, Volume: 2, Issue:1

    Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Dacarbazine; Drug Therapy, Combination; Glioma; Humans; Lomustine; Medulloblastoma; Methotrexate; Nitrogen Mustard Compounds; Procarbazine; Semustine; Teniposide; Vincristine

1975
Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.
    The American journal of pediatric hematology/oncology, 1990,Summer, Volume: 12, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Minnesota; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, High-Energy; Retrospective Studies; Survival Rate; Vinblastine; Vincristine

1990
[Results of the treatment of lymphogranulomatosis].
    Terapevticheskii arkhiv, 1986, Volume: 58, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine

1986
[Rescue treatment in Hodgkin's disease].
    Sangre, 1987, Volume: 32, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine

1987
[Chemotherapy of malignant melanoma].
    Annales de dermatologie et de venereologie, 1988, Volume: 115, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Humans; Interferons; Interleukin-2; Lomustine; Melanoma; Prognosis; Skin Neoplasms; Tamoxifen

1988
Treatment of advanced Hodgkin's disease.
    Hematology/oncology clinics of North America, 1989, Volume: 3, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine

1989
Chemotherapy for soft tissue sarcoma.
    Surgery, gynecology & obstetrics, 1986, Volume: 162, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Humans; Lomustine; Sarcoma; Soft Tissue Neoplasms; Vincristine

1986
Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
    Cancer research, 1982, Volume: 42, Issue:11

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Mutation; Prednisone; Procarbazine; Vinblastine; Vincristine

1982
[The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine

1998
Melanoma-associated retinopathy: does autoimmunity prolong survival?
    Clinical & experimental ophthalmology, 2001, Volume: 29, Issue:4

    Topics: Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Autoimmunity; Dacarbazine; Female; Humans; Immunosuppression Therapy; Interneurons; Lomustine; Melanoma; Membrane Proteins; Paraneoplastic Syndromes; Proteins; Retina; Retinal Diseases; Skin Neoplasms; Survival Rate

2001
Chemotherapy for the treatment of oligodendroglial tumors.
    Seminars in oncology, 2001, Volume: 28, Issue:4 Suppl 13

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials as Topic; Dacarbazine; Humans; Lomustine; Oligodendroglioma; Procarbazine; Prognosis; Temozolomide; Vincristine

2001
Adults with newly diagnosed high-grade gliomas.
    Current treatment options in oncology, 2001, Volume: 2, Issue:6

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Contraindications; Cranial Irradiation; Craniotomy; Dacarbazine; Disease Progression; Epidemiologic Methods; Glioblastoma; Humans; Isotretinoin; Lomustine; Palliative Care; Procarbazine; Radiosurgery; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Temozolomide; Treatment Outcome; Vincristine

2001
Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis.
    Surgical neurology, 2003, Volume: 60, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Diagnosis, Differential; Humans; Incidence; Lomustine; Oligodendroglioma; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Temozolomide; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine

2003
Systemic chemotherapy in the treatment of malignant melanoma.
    Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Humans; Lomustine; Melanoma; Neoplasm Metastasis; Skin Neoplasms; Tamoxifen; Treatment Outcome; Vincristine

2003
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.
    Neurology, 2004, Aug-10, Volume: 63, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Artifacts; Astrocytoma; Brain Edema; Brain Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Cohort Studies; Combined Modality Therapy; Contrast Media; Cranial Irradiation; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Gadolinium; Glioma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Patient Selection; Procarbazine; Temozolomide; Vincristine

2004
Treatment of Hodgkin lymphoma: the past, present, and future.
    Nature clinical practice. Oncology, 2008, Volume: 5, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine

2008
[Clinicopathological diagnosis of gliomas by genotype analysis].
    Brain and nerve = Shinkei kenkyu no shinpo, 2009, Volume: 61, Issue:7

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Genotype; Glioblastoma; Humans; Lomustine; Loss of Heterozygosity; Molecular Diagnostic Techniques; Pharmacogenetics; Procarbazine; Prognosis; Temozolomide; Tumor Suppressor Proteins; Vincristine

2009
[Treatment of glioma with temozolomide].
    Brain and nerve = Shinkei kenkyu no shinpo, 2009, Volume: 61, Issue:7

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Dacarbazine; DNA Damage; Glioblastoma; Humans; Leukemia, Myeloid, Acute; Lomustine; Myelodysplastic Syndromes; Neoplasms, Second Primary; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide

2009
Chemotherapy in low-grade gliomas.
    Current opinion in oncology, 2012, Volume: 24, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Clinical Trials as Topic; Dacarbazine; Glioma; Humans; Lomustine; Procarbazine; Temozolomide; Treatment Outcome; Vincristine

2012
[Management of gliomas].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:5-6

    Topics: Age Factors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Chemoradiotherapy; Chromosome Deletion; Chromosomes, Human, Pair 1; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Dose Fractionation, Radiation; Drug Resistance, Neoplasm; Glioma; Humans; Lomustine; Methylation; Multicenter Studies as Topic; Neoplasm Proteins; Neurosurgical Procedures; O(6)-Methylguanine-DNA Methyltransferase; Procarbazine; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Temozolomide; Treatment Outcome; Vincristine

2014
Antiangiogenic therapy for high-grade glioma.
    The Cochrane database of systematic reviews, 2014, Sep-22, Issue:9

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Camptothecin; Dacarbazine; Glioblastoma; Humans; Hypertension; Irinotecan; Lomustine; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Proteinuria; Randomized Controlled Trials as Topic; Snake Venoms; Temozolomide

2014
Low-grade gliomas.
    Continuum (Minneapolis, Minn.), 2015, Volume: 21, Issue:2 Neuro-on

    Topics: Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease Progression; Glioma; Humans; Isocitrate Dehydrogenase; Lomustine; Mutation; Procarbazine; Temozolomide; Treatment Outcome; Vincristine

2015
Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?
    CNS oncology, 2015, Volume: 4, Issue:5

    Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Dacarbazine; Humans; Lomustine; Oligodendroglioma; Procarbazine; Temozolomide; Treatment Outcome; Vincristine

2015
Nitrosoureas in the Management of Malignant Gliomas.
    Current neurology and neuroscience reports, 2016, Volume: 16, Issue:2

    Topics: Dacarbazine; Glioma; Humans; Lomustine; Nitrosourea Compounds; Organophosphorus Compounds; Procarbazine; Temozolomide; Vincristine

2016
Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
    The Cochrane database of systematic reviews, 2017, 07-26, Volume: 7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cytarabine; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Glioma; Humans; Hydroxyurea; Lomustine; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Procarbazine; Randomized Controlled Trials as Topic; Temozolomide; Vincristine

2017
Anti-angiogenic therapy for high-grade glioma.
    The Cochrane database of systematic reviews, 2018, 11-22, Volume: 11

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Camptothecin; Dacarbazine; Glioblastoma; Humans; Hypertension; Irinotecan; Lomustine; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Progression-Free Survival; Proteinuria; Randomized Controlled Trials as Topic; Snake Venoms; Temozolomide

2018

Trials

60 trial(s) available for lomustine and dacarbazine

ArticleYear
Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy.
    Cancer treatment reports, 1979, Volume: 63, Issue:1

    Topics: Adult; Aged; Bleomycin; Clinical Trials as Topic; Dacarbazine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Vincristine

1979
A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas.
    Cancer treatment reports, 1976, Volume: 60, Issue:9

    Topics: Adult; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fibrosarcoma; Hemangiopericytoma; Histiocytoma, Benign Fibrous; Humans; Leiomyosarcoma; Lomustine; Male; Mesothelioma; Neurofibroma; Nitrosourea Compounds; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Triazenes; Vincristine

1976
DTIC (NSC-45388) in malignant melanoma: a perspective.
    Cancer treatment reports, 1976, Volume: 60, Issue:2

    Topics: Animals; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Humans; Lomustine; Melanoma; Mice; Neoplasm Metastasis; Nitrosourea Compounds; Remission, Spontaneous; Triazenes

1976
Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.
    Cancer treatment reports, 1976, Volume: 60, Issue:2

    Topics: Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukopenia; Lomustine; Male; Melanoma; Middle Aged; Nausea; Sex Factors; Thrombocytopenia; Triazenes; Vincristine; Vomiting

1976
Eastern Cooperative Oncology Group studies with DTIC (NSC-45388).
    Cancer treatment reports, 1976, Volume: 60, Issue:2

    Topics: Adult; Aged; Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Sex Factors; Skin Neoplasms; Triazenes

1976
DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
    Cancer treatment reports, 1976, Volume: 60, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carmustine; Dacarbazine; Drug Therapy, Combination; Humans; Hydroxyurea; Lomustine; Melanoma; Middle Aged; Triazenes; United States; Vincristine

1976
Combination chemotherapy in disseminated melanoma and other solid tumors in adults.
    Oncology, 1975, Volume: 31, Issue:1

    Topics: Clinical Trials as Topic; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Humans; Lomustine; Melanoma; Neoplasms; Nitrosourea Compounds; Triazenes

1975
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
    Medizinische Klinik (Munich, Germany : 1983), 1992, Nov-15, Volume: 87, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine

1992
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hematocrit; Hodgkin Disease; Humans; Lomustine; Lymphatic Metastasis; Male; Mechlorethamine; Melphalan; Middle Aged; Models, Biological; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Analysis; Vinblastine; Vincristine; Vindesine

1990
[Results of a randomized polychemotherapy study in malignant melanoma].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1990, Volume: 41, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Follow-Up Studies; Humans; Lomustine; Lymphatic Metastasis; Melanoma; Middle Aged; Neoplasm Staging; Prospective Studies; Randomized Controlled Trials as Topic; Skin Neoplasms; Vincristine

1990
Association between chemotherapy response and rate of disease progression in disseminated melanoma.
    British journal of cancer, 1991, Volume: 63, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Prognosis; Time Factors

1991
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
    Annals of internal medicine, 1986, Volume: 104, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednimustine; Prednisone; Procarbazine; Prospective Studies; Random Allocation; Recurrence; Vinblastine; Vincristine

1986
[Intermediate results of the German Hodgkin's disease therapy study].
    Onkologie, 1986, Volume: 9, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Germany, West; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine; Vindesine

1986
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3].
    Onkologie, 1987, Volume: 10, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Pilot Projects; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine; Vindesine

1987
Treatment of advanced Hodgkin's disease.
    Hematology/oncology clinics of North America, 1989, Volume: 3, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine

1989
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 117

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine

1989
[Combination chemotherapy of disseminated skin melanoma with nitrosomethylurea].
    Archiv fur Geschwulstforschung, 1986, Volume: 56, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dacarbazine; Dactinomycin; Drug Administration Schedule; Humans; Lomustine; Melanoma; Methylnitrosourea; Prognosis; Skin Neoplasms; Vincristine

1986
Cytotoxic chemotherapy of disseminated cutaneous malignant melanoma--a prospective and randomized clinical trial of procarbazine, vindesine and lomustine versus procarbazine, DTIC and lomustine.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Evaluation; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Procarbazine; Prospective Studies; Random Allocation; Skin Neoplasms; Vindesine

1986
Adjuvant chemotherapy of malignant melanoma. A pilot study.
    American journal of clinical oncology, 1985, Volume: 8, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Pilot Projects; Random Allocation; Skin Neoplasms; Vincristine

1985
Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
    Cancer, 1983, Apr-15, Volume: 51, Issue:8

    Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Thrombocytopenia; Vinblastine; Vincristine

1983
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations.
    The American journal of medicine, 1984, Volume: 76, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine

1984
Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma. IV. Late results after complete response to chemotherapy (Central Oncology Group protocols 7130, 7131, and 7131A).
    Cancer, 1984, Mar-15, Volume: 53, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Dacarbazine; Female; Humans; Hydroxyurea; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Sex Factors; Skin Neoplasms; Soft Tissue Neoplasms; Time Factors; Vincristine

1984
Treatment of patients with metastatic melanoma with a one day regimen of dacarbazine, vincristine, bleomycin and lomustine plus interferon-alpha.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Treatment Outcome; Vincristine

1994
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
    Leukemia & lymphoma, 1994, Volume: 14, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Failure; Vinblastine; Vincristine; Vindesine

1994
Intermittent interferon and polychemotherapy in metastatic melanoma.
    Journal of cancer research and clinical oncology, 1995, Volume: 121, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Drug Administration Schedule; Evaluation Studies as Topic; Female; Humans; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Vincristine

1995
Ototoxicity in children with malignant brain tumors treated with the "8 in 1" chemotherapy protocol.
    Medical and pediatric oncology, 1996, Volume: 27, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Administration Schedule; Evaluation Studies as Topic; Female; Follow-Up Studies; Hearing Loss; Humans; Hydroxyurea; Incidence; Infant; Lomustine; Male; Methylprednisolone; Procarbazine; Radiation Injuries; Risk Factors; Vincristine

1996
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG).
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine; Vindesine

1995
Complete responses and survival after polychemotherapy plus interferon-alpha for patients with metastatic melanoma.
    Melanoma research, 1996, Volume: 6, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Female; Humans; Immunotherapy; Interferon alpha-2; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Nimustine; Recombinant Proteins; Treatment Outcome; Vincristine

1996
Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.
    British journal of cancer, 1997, Volume: 76, Issue:2

    Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Dacarbazine; Female; Humans; Immunotherapy; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Staging; Skin Neoplasms; Treatment Outcome; Vincristine

1997
BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy.
    Journal of experimental & clinical cancer research : CR, 1997, Volume: 16, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Interferon alpha-2; Interferon-alpha; Lomustine; Lung Diseases; Male; Melanoma; Middle Aged; Recombinant Proteins; Uveal Neoplasms; Vincristine

1997
High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma.
    International journal of cancer, 2002, Feb-01, Volume: 97, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Division; Collagenases; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Enzyme Induction; Female; Humans; Immunologic Factors; Immunotherapy; Interferon-alpha; Interleukin-2; Lomustine; Male; Matrix Metalloproteinase 3; Melanins; Melanocytes; Melanoma; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Prognosis; Radiotherapy, Adjuvant; Vincristine

2002
Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma.
    Cancer, 2002, Dec-01, Volume: 95, Issue:11

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Female; Humans; Injections, Intravenous; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Treatment Outcome; Uveal Neoplasms; Vincristine

2002
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
    Cancer, 2002, Dec-15, Volume: 95, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome; Up-Regulation; Vinblastine; Vincristine

2002
A prospective study on glioblastoma in the elderly.
    Cancer, 2003, Feb-01, Volume: 97, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Dacarbazine; Female; Glioblastoma; Humans; Lomustine; Male; Neurosurgical Procedures; Procarbazine; Prospective Studies; Radiotherapy Dosage; Survival Analysis; Temozolomide; Vincristine

2003
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:4

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Temozolomide; Treatment Outcome; Vincristine

2003
Low-dose continuous chemotherapy for metastatic melanoma: a phase II trial.
    Melanoma research, 2003, Volume: 13, Issue:2

    Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Dacarbazine; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lomustine; Male; Melanoma; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Tamoxifen; Time Factors; Treatment Outcome; Vinblastine

2003
Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma.
    European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Feasibility Studies; Female; Humans; Interferon alpha-2; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prospective Studies; Recombinant Proteins; Treatment Outcome; Uveal Neoplasms; Vincristine

2003
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Jun-15, Volume: 21, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine

2003
Initial chemotherapy in gliomatosis cerebri.
    Neurology, 2004, Jul-27, Volume: 63, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Karnofsky Performance Status; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Neuroepithelial; Oligodendroglioma; Procarbazine; Survival Analysis; Temozolomide; Treatment Outcome; Vincristine

2004
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.
    Neurology, 2004, Aug-10, Volume: 63, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Artifacts; Astrocytoma; Brain Edema; Brain Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Cohort Studies; Combined Modality Therapy; Contrast Media; Cranial Irradiation; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Gadolinium; Glioma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Patient Selection; Procarbazine; Temozolomide; Vincristine

2004
Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas.
    Neurology, 2004, Sep-14, Volume: 63, Issue:5

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Cohort Studies; Dacarbazine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Remission Induction; Retrospective Studies; Salvage Therapy; Sequence Deletion; Temozolomide; Treatment Outcome; Vincristine

2004
Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma.
    Melanoma research, 2005, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Interferon Type I; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vincristine

2005
Phase I study of temozolomide and lomustine in the treatment of high grade malignant glioma.
    Frontiers in bioscience : a journal and virtual library, 2006, Jan-01, Volume: 11

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cohort Studies; Dacarbazine; Dose-Response Relationship, Drug; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Temozolomide; Time Factors

2006
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-20, Volume: 23, Issue:36

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2005
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Sep-20, Volume: 24, Issue:27

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; DNA Methylation; Drug Administration Schedule; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Predictive Value of Tests; Prognosis; Promoter Regions, Genetic; Radiotherapy, Adjuvant; Survival Analysis; Temozolomide; Treatment Outcome

2006
A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.
    British journal of cancer, 2007, Jan-15, Volume: 96, Issue:1

    Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lomustine; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neutropenia; Temozolomide; Thrombocytopenia; Treatment Failure

2007
Influence of therapy on the antioxidant status in patients with melanoma.
    Journal of clinical pharmacy and therapeutics, 2008, Volume: 33, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Catalase; Dacarbazine; Female; Humans; Lipid Peroxidation; Lomustine; Male; Malondialdehyde; Melanoma; Middle Aged; Oxidative Stress; Superoxide Dismutase

2008
A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood.
    Neuro-oncology, 2008, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Dacarbazine; Glioma; Humans; Lomustine; Maximum Tolerated Dose; Temozolomide

2008
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Dec-10, Volume: 27, Issue:35

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Disease Progression; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Administration Schedule; Female; Glioma; Humans; Isocitrate Dehydrogenase; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Mutation; Procarbazine; Promoter Regions, Genetic; Proportional Hazards Models; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Temozolomide; Time Factors; Treatment Failure; Tumor Suppressor Proteins; Vincristine; Young Adult

2009
Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.
    Neurosurgery, 2010, Volume: 66, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Cross-Linking Reagents; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Injections, Intra-Arterial; Lomustine; Male; Melphalan; Middle Aged; Oligodendroglioma; Osmotic Pressure; Procarbazine; Temozolomide; Vincristine; Young Adult

2010
Impact of adjuvant chemotherapy for gliomatosis cerebri.
    BMC cancer, 2010, Aug-13, Volume: 10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Child; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Female; Humans; Lomustine; Male; Middle Aged; Neoplasm Staging; Neoplasms, Neuroepithelial; Neoplasms, Radiation-Induced; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Temozolomide; Vincristine; Young Adult

2010
Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Oct-20, Volume: 28, Issue:30

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Glioma; Humans; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Neoplasm Staging; Procarbazine; Proportional Hazards Models; Quality of Life; Recurrence; Risk Assessment; Risk Factors; Temozolomide; Time Factors; Treatment Outcome; United Kingdom; Vincristine

2010
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:3

    Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2012
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-10, Volume: 29, Issue:32

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine

2011
Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial.
    Acta neuropathologica communications, 2014, Jun-20, Volume: 2

    Topics: Antineoplastic Agents; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Mutational Analysis; DNA Repair Enzymes; DNA, Neoplasm; Female; Glioma; Humans; Isocitrate Dehydrogenase; Lomustine; Male; Predictive Value of Tests; Temozolomide; Tumor Suppressor Proteins; Vincristine

2014
Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma.
    Anticancer research, 2015, Volume: 35, Issue:10

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Glioma; Humans; Indoles; Lomustine; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Pyrroles; Sunitinib; Survival Rate; Temozolomide

2015
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Apr-10, Volume: 34, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2016
The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide.
    Journal of neuro-oncology, 2016, Volume: 127, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carmustine; Dacarbazine; Female; Follow-Up Studies; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Temozolomide; Vincristine

2016
Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.
    Neuro-oncology, 2016, Volume: 18, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Female; Glioma; Humans; Lomustine; Male; Temozolomide; Young Adult

2016
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.
    Journal of neuro-oncology, 2023, Volume: 161, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Glioblastoma; Humans; Lomustine; Prognosis; Temozolomide

2023

Other Studies

112 other study(ies) available for lomustine and dacarbazine

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:4

    Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Morphological responses of benign human prostatic hypertrophic tissue to chemotherapeutic agents in an in vitro culture system.
    Journal of medicine, 1975, Volume: 6, Issue:1

    Topics: Aged; Altretamine; Dacarbazine; Fluorouracil; Humans; Lomustine; Male; Microscopy; Middle Aged; Organ Culture Techniques; Procarbazine; Prostate; Prostatic Hyperplasia; Streptozocin; Vincristine

1975
[Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1976, Aug-06, Volume: 101, Issue:32

    Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine

1976
[Cytostatic chemotherapy of lymphogranulomatosis].
    Deutsche medizinische Wochenschrift (1946), 1978, Feb-10, Volume: 103, Issue:6

    Topics: Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Procarbazine; Remission, Spontaneous; Vinblastine; Vincristine

1978
Failure of methyl-C.C.N.U. and 5-fluorouracil in colorectal cancer.
    Lancet (London, England), 1978, Jul-08, Volume: 2, Issue:8080

    Topics: Adult; Aged; Colonic Neoplasms; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Rectal Neoplasms

1978
An A,B,C,D of cancer chemotherapy.
    The Western journal of medicine, 1979, Volume: 130, Issue:6

    Topics: Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine

1979
Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441).
    Cancer, 1975, Volume: 36, Issue:4

    Topics: Adult; Brain Neoplasms; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Female; Glioblastoma; Humans; Leukopenia; Lomustine; Male; Methylnitrosourea; Middle Aged; Thrombocytopenia; Triazenes

1975
Results of a nonrandomized trial in malignant melanoma patients (Clark's stages III--V) treated by post-surgical chemoimmunotherapy.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1978, Volume: 68

    Topics: Antineoplastic Agents; BCG Vaccine; Dacarbazine; Drug Therapy, Combination; Humans; Lomustine; Melanoma; Neoplasm Staging; Vincristine

1978
Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Cancer treatment reports, 1976, Volume: 60, Issue:2

    Topics: BCG Vaccine; Blood Cell Count; Dacarbazine; Drug Therapy, Combination; Humans; Immunotherapy; Lomustine; Melanoma; Mycobacterium bovis; Neoplasm Metastasis; Propionibacterium acnes; Remission, Spontaneous; Triazenes; Vincristine

1976
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?
    Surgery, gynecology & obstetrics, 1976, Volume: 142, Issue:6

    Topics: Adult; Altretamine; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carmustine; Colonic Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lomustine; Lung Neoplasms; Male; Melanoma; Mitolactol; Neoplasms; Osteosarcoma; Pancreatic Neoplasms; Rectal Neoplasms; Vincristine

1976
Single drug and combination chemotherapy in the treatment. Disseminated malignant melanoma.
    Minnesota medicine, 1977, Volume: 60, Issue:8

    Topics: Antineoplastic Agents; Carmustine; Dacarbazine; Drug Therapy, Combination; Humans; Hydroxyurea; Lomustine; Melanoma; Neoplasm Metastasis; Skin Neoplasms; Vincristine

1977
Chemotherapy of a human malignant melanoma transplanted in the nude mouse.
    Cancer research, 1975, Volume: 35, Issue:10

    Topics: Animals; Body Weight; Dacarbazine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fluorouracil; Lomustine; Male; Melanoma; Mice; Mice, Nude; Models, Biological; Neoplasm Transplantation; Nitrosourea Compounds; Transplantation, Heterologous; Triazenes

1975
A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Drug Administration Schedule; Female; Humans; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Treatment Outcome; Vincristine

1992
Nine years' experience of BELD combination chemotherapy (bleomycin, vindesine, CCNU and DTIC) for metastatic melanoma.
    The British journal of dermatology, 1992, Volume: 127, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Staging; Survival Rate; Vindesine

1992
Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
    Cancer research, 1990, Feb-01, Volume: 50, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Chromosomes; Dacarbazine; DNA Damage; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Nitroso Compounds; Prednisone; Procarbazine; Sister Chromatid Exchange; Vinblastine; Vincristine

1990
Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit.
    British journal of cancer, 1990, Volume: 61, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; Female; Humans; Lomustine; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Vincristine; Vindesine

1990
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1990, Volume: 1, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine

1990
Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only, for both localized and advanced disease.
    International journal of cancer, 1991, Apr-01, Volume: 47, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Saudi Arabia; Vinblastine; Vincristine

1991
New approaches to the chemotherapy of melanoma.
    Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:5

    Topics: Alkaloids; Amifostine; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Daunorubicin; Humans; Lomustine; Melanoma; Nitrosourea Compounds; Paclitaxel; Procarbazine; Tamoxifen; Taurine; Thiotepa; Vincristine; Vindesine

1991
The prognosis of melanoma patients with metastases to two or more lymph node areas.
    Annals of surgery, 1991, Volume: 214, Issue:2

    Topics: Adolescent; Adult; BCG Vaccine; Combined Modality Therapy; Dacarbazine; Female; Humans; Immunotherapy; Lomustine; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Prognosis; Skin Neoplasms; Survival Rate

1991
In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea.
    Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:5

    Topics: Antineoplastic Agents; Carmustine; Cell Division; Cisplatin; Dacarbazine; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Lomustine; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Thymidine; Tumor Cells, Cultured

1990
CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
    Seminars in oncology, 1986, Volume: 13, Issue:1 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednimustine; Prednisone; Procarbazine; Time Factors; Vinblastine; Vincristine

1986
[Early results of the treatment of Hodgkin's disease with alternating use in the CVPP and ABVD protocol].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1986, Feb-17, Volume: 41, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine

1986
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the Ge
    Cancer treatment reports, 1987, Volume: 71, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Multi-Institutional Systems; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine

1987
Bleomycin, vincristine, lomustine, and DTIC chemotherapy for metastatic melanoma.
    Cancer, 1988, Jun-01, Volume: 61, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Humans; Lomustine; Melanoma; Neoplasm Metastasis; Vincristine

1988
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Italy; Lomustine; Male; Mechlorethamine; Prednimustine; Prednisone; Procarbazine; Transplantation, Autologous; Vinblastine; Vincristine

1988
[Treatment with CEP (CCNU, VP-16 and prednimustine) in Hodgkin's disease resistant to CVPP and ABVD. Results in 21 patients].
    Sangre, 1988, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednimustine; Prednisone; Procarbazine; Vinblastine; Vincristine

1988
Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). The Prudente Foundation Melanoma Study Group.
    Cancer, 1989, May-01, Volume: 63, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Drug Administration Schedule; Female; Humans; Lomustine; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Skin Neoplasms; Vincristine

1989
[Treatment of Hodgkin's disease with alternately used drug combinations CVPP/ABVD].
    Przeglad lekarski, 1988, Volume: 45, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine

1988
Effectiveness and toxicity of "BELD" polychemotherapy in advanced malignant melanoma.
    Tumori, 1989, Jun-30, Volume: 75, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Lomustine; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Remission Induction; Skin Neoplasms; Vindesine

1989
Third-line salvage chemotherapy in Hodgkin's disease.
    Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Vinblastine; Vincristine

1985
The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma.
    Cancer, 1985, May-01, Volume: 55, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Drug Administration Schedule; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pilot Projects; Skin Neoplasms; Vinblastine; Vindesine

1985
[Chemotherapy and combined chemo- and radiotherapy of small cell lung cancer].
    Voprosy onkologii, 1985, Volume: 31, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Humans; Lomustine; Lung Neoplasms; Methotrexate; Methylnitrosourea; Procarbazine; Prospidium; Vincristine

1985
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Evaluation; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methylprednisolone; Neoplasm Recurrence, Local; Procarbazine; Vincristine

1987
Predictive chemosensitivity testing in malignant melanoma: reliable methodology--ineffective drugs.
    British journal of cancer, 1988, Volume: 58, Issue:6

    Topics: Dacarbazine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lomustine; Melanoma; Predictive Value of Tests; Prospective Studies; Retrospective Studies; Vinblastine

1988
[Systemic therapy of metastatic malignant melanoma].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1988, Apr-26, Volume: 77, Issue:17

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Humans; Immunotherapy; Interferon Type I; Interleukin-2; Killer Cells, Natural; Lomustine; Melanoma; Skin Neoplasms

1988
[Efficacy of the "8 drugs in a day" protocol in brain tumors in children].
    Archives francaises de pediatrie, 1988, Volume: 45, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cytarabine; Cytidine Diphosphate Diglycerides; Dacarbazine; Female; Glioma; Humans; Hydroxyurea; Infant; Lomustine; Male; Medulloblastoma; Methylprednisolone; Procarbazine; Vincristine

1988
Sequential treatment with interferon and chemotherapy of metastatic malignant melanoma. Total remission of cutaneous and visceral metastasis, but not of cerebral metastasis.
    Tumori, 1987, Feb-28, Volume: 73, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carmustine; Combined Modality Therapy; Dacarbazine; Drug Evaluation; Female; Humans; Interferon Type I; Lomustine; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Recombinant Proteins; Skin Neoplasms; Vincristine

1987
Radiation therapy for brain metastases from malignant melanoma.
    Acta radiologica. Oncology, 1984, Volume: 23, Issue:4

    Topics: Adult; Aged; Brain Neoplasms; Dacarbazine; Dose-Response Relationship, Radiation; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Prognosis

1984
Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease.
    Cancer, 1980, Dec-01, Volume: 46, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukopenia; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Thrombocytopenia; Vincristine

1980
[Chemotherapy in pretreated Hodgkin's disease with lomustine, bleomycin, vinblastine and dexamethasone].
    Deutsche medizinische Wochenschrift (1946), 1983, Sep-23, Volume: 108, Issue:38

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Prednisone; Procarbazine; Vinblastine; Vincristine

1983
Management of malignant melanoma: a retrospective analysis of 182 patients.
    Clinical radiology, 1984, Volume: 35, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Lomustine; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Retrospective Studies; Skin Neoplasms

1984
Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1983, Volume: 1, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Prednisone; Procarbazine; Vincristine

1983
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
    Annals of internal medicine, 1984, Volume: 101, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Resistance; Female; Heart Diseases; Hodgkin Disease; Humans; Lomustine; Lung Diseases; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Vinblastine; Vincristine

1984
Modern problems of clinical chemotherapy of malignant tumours.
    Archiv fur Geschwulstforschung, 1980, Volume: 50, Issue:7

    Topics: Antineoplastic Agents; Carcinoma, Small Cell; Carubicin; Dacarbazine; Dactinomycin; Drug Therapy, Combination; Female; Humans; Lomustine; Lung Neoplasms; Male; Melanoma; Methylnitrosourea; Neoplasms; Sarcoma; Skin Neoplasms; Soft Tissue Neoplasms; Vincristine

1980
Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma.
    International journal of tissue reactions, 1984, Volume: 6, Issue:6

    Topics: Aged; B-Lymphocytes; Dacarbazine; Female; Humans; Leukocyte Count; Lomustine; Lymphocytes; Male; Melanoma; Middle Aged; Neoplasm Metastasis; T-Lymphocytes

1984
In vitro sensitivity of human melanoma xenografts to cytotoxic drugs. Correlation with in vivo chemosensitivity.
    International journal of cancer, 1980, Dec-15, Volume: 26, Issue:6

    Topics: Abrin; Animals; Antineoplastic Agents; Dacarbazine; Humans; Lomustine; Melanoma; Mice; Mice, Nude; Neoplasms, Experimental; Procarbazine; Ricin; Vinblastine

1980
Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.
    British journal of cancer, 1981, Volume: 44, Issue:4

    Topics: Abrin; Agar; Animals; Cell Survival; Cells, Cultured; Dacarbazine; Drug Evaluation, Preclinical; Erythrocytes; Humans; Lomustine; Melanoma; Oxygen Consumption; Rats; Vinblastine

1981
The usefulness of human tumor cell lines in the study of chemosensitivity. A study of malignant melanomas.
    International journal of cancer, 1981, Oct-15, Volume: 28, Issue:4

    Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Dacarbazine; Drug Evaluation, Preclinical; Humans; Lomustine; Melanoma; Mice; Neoplasm Transplantation; Procarbazine; Ricin; Transplantation, Heterologous; Vinblastine

1981
Metastatic tumor to the retina and vitreous cavity from primary melanoma of the skin: treatment with systemic and subconjunctival chemotherapy.
    Ophthalmology, 1981, Volume: 88, Issue:12

    Topics: Adult; Carmustine; Dacarbazine; Eye Neoplasms; Female; Humans; Lomustine; Melanoma; Retina; Skin Neoplasms; Vitreous Body

1981
Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice.
    International journal of cancer, 1980, Apr-15, Volume: 25, Issue:4

    Topics: Abrin; Animals; Antineoplastic Agents; Dacarbazine; Humans; Lomustine; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Procarbazine; Ricin; Skin Neoplasms; Time Factors; Transplantation, Heterologous; Vinblastine

1980
An inverse relationship between the growth rate of human melanoma xenografts and their response to some cytostatic drugs.
    British journal of cancer, 1980, Volume: 41, Issue:5

    Topics: Animals; Dacarbazine; Humans; Lomustine; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosourea Compounds; Procarbazine; Transplantation, Heterologous

1980
Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease.
    Cancer, 1994, Feb-15, Volume: 73, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Lomustine; Male; Middle Aged; Prednisone; Recurrence; Salvage Therapy; Survival Analysis

1994
Decreasing CD4/CD8 ratio during prolonged four-drug chemotherapy plus interferon treatment for metastatic melanoma.
    Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy, 1994, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4-CD8 Ratio; Dacarbazine; Humans; Interferon-alpha; Leukocyte Count; Lomustine; Melanoma; Middle Aged; Vincristine

1994
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Remission Induction; Treatment Outcome; Vinblastine; Vincristine

1994
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Pancytopenia; Prednisone; Procarbazine; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine; Vincristine

1994
Response of subcutaneous and cutaneous metastases of malignant melanoma to combined cytostatic plus interferon therapy.
    The British journal of dermatology, 1995, Volume: 132, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Female; Humans; Interferons; Lomustine; Male; Melanoma; Middle Aged; Skin Neoplasms; Vincristine

1995
Long term response to chemotherapy in patients with visceral metastatic melanoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Remission Induction; Semustine; Survival Rate

1994
Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells.
    British journal of cancer, 1993, Volume: 67, Issue:6

    Topics: Antineoplastic Agents; Dacarbazine; Drug Screening Assays, Antitumor; Drug Synergism; Guanine; Humans; Lomustine; Methyltransferases; Neoplasms, Experimental; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide; Tumor Cells, Cultured

1993
The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4-CD8 Ratio; Dacarbazine; Female; Humans; Immunotherapy; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Survival Analysis; Vincristine

1996
Dacarbazine, vincristine, bleomycin and lomustine plus natural interferon-alpha for metastatic melanoma.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Female; Humans; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Pilot Projects; Vincristine

1996
Chemosensitivity of human melanoma metastases in mouse subrenal capsule assay--can it predict tumour response to combined cytostatic plus interferon therapy in metastatic melanoma?
    Melanoma research, 1996, Volume: 6, Issue:3

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Confidence Intervals; Dacarbazine; Female; Humans; Interferons; Lomustine; Male; Melanoma; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Sex Characteristics; Subrenal Capsule Assay; Vincristine

1996
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapy.
    Leukemia & lymphoma, 1996, Volume: 21, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Diaphragm; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Vinblastine; Vincristine

1996
DNA flow cytometry and the outcome of chemoimmunotherapy in metastatic melanoma.
    Melanoma research, 1997, Volume: 7, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; DNA, Neoplasm; Female; Flow Cytometry; Humans; Immunotherapy; Interferons; Lomustine; Male; Melanoma; Middle Aged; Ploidies; Treatment Outcome; Vincristine

1997
Sensitivity of short-term cultures derived from human malignant glioma to the anti-cancer drug temozolomide.
    Anti-cancer drugs, 1999, Volume: 10, Issue:2

    Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Dacarbazine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Glioblastoma; Humans; Inhibitory Concentration 50; Lomustine; Oligodendroglioma; Temozolomide; Tumor Cells, Cultured

1999
[Chemotherapy of malignant melanoma].
    Polskie Archiwum Medycyny Wewnetrznej, 1998, Volume: 100, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dacarbazine; Humans; Immunotherapy; Interleukins; Lomustine; Melanoma; Middle Aged; Palliative Care; Skin Neoplasms; Tamoxifen; Vincristine

1998
Modulating effect of new potential antimelanomic agents, spin-labeled triazenes and nitrosoureas on the DOPA-oxidase activity of tyrosinase.
    Cancer biochemistry biophysics, 1999, Volume: 17, Issue:1-2

    Topics: Animals; Antineoplastic Agents, Alkylating; Catalysis; Cyclic N-Oxides; Dacarbazine; Dihydroxyphenylalanine; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Lomustine; Melanoma, Experimental; Mice; Molecular Structure; Monophenol Monooxygenase; Neoplasm Proteins; Nitrosourea Compounds; Oxidation-Reduction; Piperidines; Plant Proteins; Spectrophotometry; Spin Labels; Structure-Activity Relationship; Triazenes; Tumor Cells, Cultured

1999
Analysis of G(1)/S checkpoint regulators in metastatic melanoma.
    Genes, chromosomes & cancer, 2000, Volume: 28, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Lomustine; Male; Melanoma; Middle Aged; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; S Phase; Survival Analysis; Treatment Outcome; Vincristine

2000
Radiotherapy of esthesioneuroblastoma.
    International journal of radiation oncology, biology, physics, 2001, Jan-01, Volume: 49, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Dacarbazine; Doxorubicin; Esthesioneuroblastoma, Olfactory; Female; Follow-Up Studies; Humans; Lomustine; Male; Nasal Cavity; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Vincristine

2001
Stress and chemotherapy. Combined effects on tumor progression and immunity in animal models.
    Annals of the New York Academy of Sciences, 2000, Volume: 917

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Immunosuppressive Agents; Lomustine; Lung Neoplasms; Mice; Stress, Physiological

2000
Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones.
    European journal of haematology, 2001, Volume: 67, Issue:1

    Topics: Alkylating Agents; Alkylation; Animals; Carmustine; Cells, Cultured; Colony-Forming Units Assay; Dacarbazine; DNA Damage; DNA, Complementary; Drug Resistance; Genetic Vectors; Hematopoietic Stem Cells; Humans; Lomustine; Mice; Moloney murine leukemia virus; Nimustine; O(6)-Methylguanine-DNA Methyltransferase; Recombinant Fusion Proteins; Retroviridae; Sarcoma Viruses, Murine; Spleen Focus-Forming Viruses; Temozolomide; Terminal Repeat Sequences; Transfection

2001
Interobserver variability in the radiological assessment of response to chemotherapy in glioma.
    Neurology, 2003, Mar-11, Volume: 60, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Ependymoma; Female; Glioblastoma; Glioma; Humans; Image Enhancement; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Paclitaxel; Procarbazine; Sensitivity and Specificity; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2003
Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center.
    Wiener klinische Wochenschrift, 2003, Jun-24, Volume: 115, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Clinical Trials as Topic; Cobalt Radioisotopes; Combined Modality Therapy; Dacarbazine; Female; Glioblastoma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Radiotherapy Dosage; Survival Analysis; Time Factors; Tomography, X-Ray Computed

2003
Spin labeled antioxidants protect bacteria against the toxicity of alkylating antitumor drug CCNU.
    Toxicology letters, 2003, Oct-15, Volume: 144, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Antioxidants; Cyclic N-Oxides; Dacarbazine; Dose-Response Relationship, Drug; Drug Interactions; Escherichia coli; Free Radicals; Lomustine; Oxygen; Spin Labels; Staphylococcus aureus; Vitamin E

2003
Long-term outcome of oligodendrogliomas.
    Neurology, 2004, May-25, Volume: 62, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Dacarbazine; Epilepsies, Partial; Etoposide; Female; Follow-Up Studies; Humans; Life Tables; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Nitrosourea Compounds; Oligodendroglioma; Organophosphorus Compounds; Procarbazine; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi; Temozolomide; Treatment Outcome; Vincristine

2004
Gliomatosis cerebri: better definition, better treatment.
    Neurology, 2004, Jul-27, Volume: 63, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Astrocytes; Astrocytoma; Brain; Brain Neoplasms; Cell Cycle Proteins; Dacarbazine; Disease Progression; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Neuroepithelial; Nerve Tissue Proteins; Procarbazine; Temozolomide; Vincristine

2004
The prognostic role of CD4+ and CD8+ lymphocytes during chemoimmunotherapy in metastatic melanoma.
    Melanoma research, 2004, Volume: 14, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dacarbazine; Female; Humans; Immunotherapy; Interferon-alpha; Lomustine; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Prognosis; Skin Neoplasms; Survival Rate; T-Lymphocytes, Regulatory; Treatment Outcome; Vinblastine

2004
Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF.
    Japanese journal of clinical oncology, 2005, Volume: 35, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Female; Granulocyte Colony-Stimulating Factor; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Staging; Remission Induction; Skin Neoplasms; Treatment Outcome; Vincristine

2005
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma.
    Neuro-oncology, 2006, Volume: 8, Issue:3

    Topics: Adjuvants, Pharmaceutic; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Dacarbazine; Female; Humans; Lomustine; Male; Middle Aged; Procarbazine; Retrospective Studies; Survival Rate; Temozolomide; Vincristine

2006
Gliomatosis cerebri treatment in 11 elderly patients.
    Journal of experimental & clinical cancer research : CR, 2006, Volume: 25, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease Progression; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Neoplasms, Neuroepithelial; Procarbazine; Survival Rate; Temozolomide

2006
Re-evaluation of the cost effectiveness of temozolomide for malignant gliomas in British Columbia.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2006, Volume: 12, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; British Columbia; Cost-Benefit Analysis; Dacarbazine; Disease-Free Survival; Female; Glioma; Humans; Lomustine; Male; Medical Records; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Survival Rate; Temozolomide; Treatment Outcome

2006
Cryptococcal meningitis in patients with glioma: a report of two cases.
    Journal of neuro-oncology, 2008, Volume: 89, Issue:1

    Topics: Adult; Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cerebrospinal Fluid; Cryptococcus neoformans; Dacarbazine; Dexamethasone; Fatal Outcome; Fluconazole; Flucytosine; Glioma; Humans; Immunosuppression Therapy; Lomustine; Male; Meningitis, Cryptococcal; Opportunistic Infections; Temozolomide; Treatment Outcome

2008
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.
    British journal of cancer, 2008, Jul-22, Volume: 99, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytes; Carboplatin; Cell Line, Tumor; Cisplatin; Dacarbazine; Drug Screening Assays, Antitumor; Etoposide; Female; Glioblastoma; Glioma; Hepatocytes; Humans; Lomustine; Male; Membrane Glycoproteins; Middle Aged; Procarbazine; Recombinant Fusion Proteins; Temozolomide; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Vincristine

2008
Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19 Suppl 7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Glioma; Humans; Lomustine; Neoplasm Recurrence, Local; Procarbazine; Prognosis; Radiotherapy; Radiotherapy Dosage; Temozolomide; Vincristine

2008
Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
    Acta oncologica (Stockholm, Sweden), 2009, Volume: 48, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Catheter Ablation; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Humans; Immunotherapy; Interferon Type I; Liver Neoplasms; Lomustine; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Prognosis; Recombinant Proteins; Treatment Outcome; Uveal Neoplasms; Vincristine

2009
Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Mar-10, Volume: 27, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Temozolomide

2009
Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected].
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Dec-10, Volume: 27, Issue:35

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Gene Expression Regulation, Neoplastic; Glioma; Humans; Lomustine; Procarbazine; Promoter Regions, Genetic; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Research Design; Survival Analysis; Temozolomide; Time Factors; Treatment Failure; Tumor Suppressor Proteins; Vincristine

2009
Bevacizumab is active as a single agent against recurrent malignant gliomas.
    Anticancer research, 2010, Volume: 30, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Dacarbazine; Doxorubicin; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Procarbazine; Retrospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Vincristine

2010
Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma.
    Journal of neuro-oncology, 2011, Volume: 102, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Capecitabine; Celecoxib; Dacarbazine; Deoxycytidine; Female; Fluorouracil; Glioblastoma; Gliosarcoma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Pyrazoles; Sulfonamides; Survival Rate; Temozolomide; Thioguanine; Treatment Outcome; Young Adult

2011
Expression of O⁶-methylguanine-DNA methyltransferase in childhood medulloblastoma.
    Journal of neuro-oncology, 2011, Volume: 103, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Proliferation; Cerebellar Neoplasms; Child; Child, Preschool; Dacarbazine; DNA Methylation; Female; Gene Expression Regulation, Enzymologic; Humans; Immunoenzyme Techniques; Lomustine; Male; Medulloblastoma; Multicenter Studies as Topic; Neuroectodermal Tumors, Primitive; O(6)-Methylguanine-DNA Methyltransferase; Prognosis; Promoter Regions, Genetic; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Temozolomide

2011
[Cellular markers based on DNA damage and repair (BER, MMR), expression of MLHI, MSH2, FasR, and cell death of lymphocytes as predictive parameters for clinical response to chemotherapy of melanoma].
    Tsitologiia, 2011, Volume: 53, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Death; Cisplatin; Dacarbazine; DNA Breaks, Double-Stranded; DNA Repair; Female; Gene Expression; Humans; Interferon-gamma; Ki-1 Antigen; Lomustine; Lymphocyte Count; Lymphocytes; Male; Melanoma; MutL Protein Homolog 1; MutS Homolog 2 Protein; Nuclear Proteins; Prognosis; Recombinant Proteins; Skin Neoplasms; Treatment Outcome

2011
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors.
    Neuro-oncology, 2011, Volume: 13, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, Human, Pair 1; Cohort Studies; Combined Modality Therapy; Dacarbazine; Disease Progression; Female; Follow-Up Studies; Humans; International Agencies; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Radiotherapy; Retrospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Vincristine; Young Adult

2011
[Effectiveness of DNA repair and expression of MLH1, MSH2 and FASR in lymphocytes of patients with chemotherapy-responsive, disseminated cutaneous melanoma].
    Voprosy onkologii, 2011, Volume: 57, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; DNA Damage; DNA Repair; fas Receptor; Female; Gene Expression Regulation, Neoplastic; Humans; Interferon-gamma; Lomustine; Lymphocytes; Male; Melanoma; Middle Aged; MutL Protein Homolog 1; MutS Homolog 2 Protein; Nuclear Proteins; Predictive Value of Tests; Prognosis; Skin Neoplasms; Treatment Outcome

2011
[Brain metastasis in breast cancer].
    Voprosy onkologii, 2011, Volume: 57, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Chemoradiotherapy; Dacarbazine; Dexamethasone; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Humans; Karnofsky Performance Status; Lomustine; Middle Aged; Retrospective Studies; Survival Analysis; Temozolomide; Treatment Outcome; Vincristine

2011
[Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab].
    Bulletin du cancer, 2012, Feb-01, Volume: 99, Issue:2

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Carmustine; Chemoradiotherapy; Chemotherapy, Adjuvant; Cohort Studies; Dacarbazine; Drug Therapy, Combination; Glioblastoma; Humans; Irinotecan; Lomustine; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Radiation-Sensitizing Agents; Retrospective Studies; Temozolomide

2012
Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Jul-20, Volume: 30, Issue:21

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Contrast Media; Dacarbazine; Disease Progression; Fatal Outcome; Female; Gadolinium; Glioblastoma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Radiotherapy, Adjuvant; Temozolomide; Treatment Outcome

2012
Salvage therapy with lomustine for temozolomide refractory recurrent anaplastic astrocytoma: a retrospective study.
    Journal of neuro-oncology, 2015, Volume: 122, Issue:2

    Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Biomarkers, Tumor; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Temozolomide; Young Adult

2015
Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation.
    Cancer medicine, 2015, Volume: 4, Issue:3

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Capecitabine; Celecoxib; Combined Modality Therapy; Dacarbazine; Electric Stimulation Therapy; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Temozolomide; Thioguanine; Treatment Failure

2015
Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
    Oncology (Williston Park, N.Y.), 2015, Volume: 29, Issue:4

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Dacarbazine; Evidence-Based Medicine; Glioma; Humans; Lomustine; Neoplasm Grading; Neoplasm Staging; Oligodendroglioma; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Temozolomide; Treatment Outcome; Vincristine

2015
Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for temozolomide.
    Oncology (Williston Park, N.Y.), 2015, Volume: 29, Issue:4

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Evidence-Based Medicine; Glioma; Humans; Lomustine; Neoplasm Grading; Neoplasm Staging; Oligodendroglioma; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Survival Analysis; Temozolomide; Treatment Outcome; Vincristine

2015
High-grade glioma in children and adolescents: a single-center experience.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2016, Volume: 32, Issue:2

    Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Karnofsky Performance Status; Lomustine; Male; Neurosurgical Procedures; Procarbazine; Prognosis; Proportional Hazards Models; Radiotherapy; Retrospective Studies; Survival Rate; Temozolomide; Vincristine

2016
Bacterial Sepsis Increases Survival in Metastatic Melanoma: Chlamydophila Pneumoniae Induces Macrophage Polarization and Tumor Regression.
    The Journal of investigative dermatology, 2016, Volume: 136, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlamydophila Infections; Chlamydophila pneumoniae; Dacarbazine; Humans; Lomustine; Lung Neoplasms; Macrophage Activation; Macrophages; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms; Sepsis; Skin Neoplasms; Treatment Outcome; Vincristine

2016
Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of High-Grade Glioma.
    Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:10

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bevacizumab; Brain Neoplasms; Camptothecin; Carboplatin; Chemoradiotherapy; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Cyclophosphamide; Dacarbazine; Glioblastoma; Humans; Irinotecan; Lomustine; Neoplasm Grading; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Radiotherapy; Singapore; Temozolomide; Teniposide; Vincristine

2015
Chemotherapy for intracranial ependymoma in adults.
    BMC cancer, 2016, Apr-23, Volume: 16

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Ependymoma; Epirubicin; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Procarbazine; Temozolomide; Treatment Outcome; Vincristine

2016
Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2018, Volume: 20, Issue:4

    Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Dacarbazine; DNA Mismatch Repair; Drug Resistance, Neoplasm; Glioblastoma; Humans; Lomustine; Temozolomide

2018
Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha.
    Anticancer research, 2018, Volume: 38, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Drug Administration Schedule; Female; Humans; Injections, Subcutaneous; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Staging; Survival Analysis; Treatment Outcome; Vincristine; Young Adult

2018
[Lomustine and temozolomide in combination with radiotherapy : New treatment option for patients with MGMT promoter methylated Glioblastoma].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2019, Volume: 195, Issue:9

    Topics: Antineoplastic Agents, Alkylating; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Glioblastoma; Humans; Lomustine; Temozolomide; Tumor Suppressor Proteins

2019
Triple combination of lomustine, temozolomide and irradiation reduces canine glioma cell survival in vitro.
    Veterinary medicine and science, 2023, Volume: 9, Issue:4

    Topics: Animals; Cell Survival; Dacarbazine; Dog Diseases; Dogs; Glioma; Lomustine; Temozolomide

2023
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
    Journal of neuro-oncology, 2023, Volume: 164, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Glioblastoma; Humans; Lomustine; Magnetic Resonance Imaging; Temozolomide

2023